OptiBiotix Release: Microbiome Modulating Ingredients To Aid Weight Loss To Be Presented At Vitafoods Europe
Optibiotix, one of the world leader’s in the development of human microbiome modulators, will be presenting SlimBiome®, a combination of microbiome modulating ingredients designed to improve weight loss, in the new product zone at Vitafoods Europe. The Vitafoods new product zone showcases innovative products which have come onto the market in the last 12 months.
SlimBiome® is a unique combination of glucomannan, chromium, and non-digestible prebiotic fibres, formulated by experts to support healthy weight management and weight loss. It promotes the feeling of fullness, helps burn calories by promoting a healthy metabolism, and maintains blood sugar levels to reduce food cravings and overeating. SlimBiome® has the potential to be used as an ingredient in dietary supplements, and in other over the counter (OTC) weight loss applications.
In addition, the range of GoFigure weight loss products, powered by SlimBiome®, will also be presented in the new product zone. To date, 100% of GoFigure users have reported weight loss - typically two to three pounds a week, and the range was awarded “Best New Health & Nutrition” at the 2016 European Natural & Organic Awards.
Stephen O’Hara, CEO of OptiBiotix, commented, “We are very pleased to able to present in the new product zone and show what an innovative product SlimBiome® is. Although weight loss and the microbiome have been widely understood as linked for some time, SlimBiome® represents a major step forward, because it is modulating the microbiome in a targeted way in order to aid weight loss”.
FOR MEDIA INFORMATION:
On behalf of Optibiotix Health plc
Simon Vane Percy
Vane Percy & Roberts
(T) +44 (0) 1737 821890
(e) simon@vanepercy.com
The human microbiome
The human digestive tract contains a complex and diverse ecosystem of trillions of bacteria. Recently, advances in molecular and analytical techniques (metagenomics, metabolomics) have permitted identification and quantitation of species and strains of bacteria that inhabit the gastrointestinal tract, their metabolic activity, and interactions with the human host. These studies have provided greater insight into the role of gut and their metabolites in health and disease. NIH https://commonfund.nih.gov/hmp/index
Web MD http://www.webmd.com/digestive-disorders/what-your-gut-bacteria-say-your-health#1
About OptiBiotix
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome – the collective genome of the microbes in the body – to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
About The Healthy Weight Loss Company
The Healthy Weight Loss Company (THWLC) is jointly owned by OptiBiotix Health plc (64%), Anna Maia, and Max Tomlinson. The Company was formed in July 2016 as a platform for OptiBiotix to incubate new technological solutions and develop wider product applications in weight management.
THWLC sells GoFigure® snacks and shakes containing OptiBiotix’s proprietary Slimbiome® technology under a non-exclusive UK license agreement. The use of SlimBiome® in the GoFigure® range establishes use of the technology in food products and supports the wider use of Slimbiome® technology in dietary supplements and over the counter (OTC) applications, both in the UK and internationally.
SlimBiome® is a unique combination of glucomannan, chromium, and non-digestible prebiotic fibres, formulated by experts to support healthy weight management and weight loss. It promotes the feeling of fullness, helps burn calories by promoting a healthy metabolism, and maintains blood sugar levels to reduce food cravings and overeating. SlimBiome® has the potential to be used as an ingredient in dietary supplements, and in other over the counter (OTC) weight loss applications.
In addition, the range of GoFigure weight loss products, powered by SlimBiome®, will also be presented in the new product zone. To date, 100% of GoFigure users have reported weight loss - typically two to three pounds a week, and the range was awarded “Best New Health & Nutrition” at the 2016 European Natural & Organic Awards.
Stephen O’Hara, CEO of OptiBiotix, commented, “We are very pleased to able to present in the new product zone and show what an innovative product SlimBiome® is. Although weight loss and the microbiome have been widely understood as linked for some time, SlimBiome® represents a major step forward, because it is modulating the microbiome in a targeted way in order to aid weight loss”.
FOR MEDIA INFORMATION:
On behalf of Optibiotix Health plc
Simon Vane Percy
Vane Percy & Roberts
(T) +44 (0) 1737 821890
(e) simon@vanepercy.com
The human microbiome
The human digestive tract contains a complex and diverse ecosystem of trillions of bacteria. Recently, advances in molecular and analytical techniques (metagenomics, metabolomics) have permitted identification and quantitation of species and strains of bacteria that inhabit the gastrointestinal tract, their metabolic activity, and interactions with the human host. These studies have provided greater insight into the role of gut and their metabolites in health and disease. NIH https://commonfund.nih.gov/hmp/index
Web MD http://www.webmd.com/digestive-disorders/what-your-gut-bacteria-say-your-health#1
About OptiBiotix
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome – the collective genome of the microbes in the body – to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
About The Healthy Weight Loss Company
The Healthy Weight Loss Company (THWLC) is jointly owned by OptiBiotix Health plc (64%), Anna Maia, and Max Tomlinson. The Company was formed in July 2016 as a platform for OptiBiotix to incubate new technological solutions and develop wider product applications in weight management.
THWLC sells GoFigure® snacks and shakes containing OptiBiotix’s proprietary Slimbiome® technology under a non-exclusive UK license agreement. The use of SlimBiome® in the GoFigure® range establishes use of the technology in food products and supports the wider use of Slimbiome® technology in dietary supplements and over the counter (OTC) applications, both in the UK and internationally.